The Carolina Breast Cancer Study, or CBCS, examines the causes of breast cancer. Now in Phase III, CBCS is looking into how the causes, treatments, and long-term outcomes of breast cancer differ between African-American and white women. Every year in North Carolina, approximately 5,500 women continue to be diagnosed with invasive breast cancer. Although this number remains high, the good news is that advances in research are leading to improvements in both incidence rates and long-term survival. Nearly 90% of women live 5 or more years after diagnosis, and 80% live 10 or more.
CBCS began in 1993. It is is conducted by the Lineberger Comprehensive Cancer Center in affiliation with the Gillings School of Global Public Health at the University of North Carolina at Chapel Hill. It is funded in part by the University Cancer Research Fund, the National Cancer Institute‘s Specialized Program of Research Excellence (SPORE) in breast cancer, and Susan G. Komen For the Cure.
In October 2013, we completed enrollment of nearly 3,000 participants in Phase III, named in honor of State Senator Jeanne Hopkins Lucas (pictured above). Senator Lucas was the first African-American female to serve in the North Carolina state senate, where she was a strong advocate for higher education. Senator Lucas died of breast cancer in March of 2007 at the age of 71.
Watch our informational video
Thank you to continued support from: